(-)-Cercosporamide derivatives as novel antihyperglycemic agents

Bioorganic and Medicinal Chemistry Letters

Volumn 19, Issue 3, 2009, Pages 724-726

  Furukawa, Akihiro ^a   Arita, Tsuyoshi ^a   Satoh, Susumu ^a   Araki, Kazushi ^a   Kuroha, Masanori ^a   Ohsumi, Jun ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

( ) Cercosporamide; Antihyperglycemic agent

Indexed keywords

ACETAL DERIVATIVE; ANTIDIABETIC AGENT; CERCOSPORAMIDE; CERCOSPORAMIDE DERIVATIVE; GLUCOSE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG SYNTHESIS; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; MOUSE; NONHUMAN; STRUCTURE ACTIVITY RELATION; WEIGHT REDUCTION;

ANIMALS; ANTIFUNGAL AGENTS; BENZOFURANS; BLOOD GLUCOSE; BODY WEIGHT; CHEMISTRY, PHARMACEUTICAL; DRUG DESIGN; EATING; FEEDING BEHAVIOR; HUMANS; HYPOGLYCEMIC AGENTS; INHIBITORY CONCENTRATION 50; MICE; MICE, TRANSGENIC; MODELS, CHEMICAL;

MUS;

EID: 58549093346     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2008.12.035     Document Type: Article

References (17)

1. Eckel R.H., Grundy S.M., and Zimmet P.Z. Lancet 365 (2005) 1415
2. Rotella D.P. J. Med. Chem. 47 (2004) 4111
3. Saydah S.H., Fradkin J., and Cowie C.C. J. Am. Med. Assoc. 291 (2004) 335
4. Sugawara F., Strobel S., Strobel G., Larsen R.D., Berglund D.L., Gray G., Takahashi N., Coval S.J., Stout T.J., and Clardy J. J. Org. Chem. 56 (1991) 909
5. Cooper A.B., Wang J., Saksena A.K., Girijavallabhan V., Ganguly A.K., and Chan T.-M. Tetrahedron 48 (1992) 4757
6. 4,5.
7. Sussman A., Huss K., Chio L.-C., Heidler S., Shaw M., Ma D., Zhu G., Campbell R.M., Park T.-S., Kulanthaivel P., Scott J.E., Carpenter J.W., Strege M.A., Belvo M.D., Swartling J.R., Fischl A., Yeh W.-K., Shih C., and Ye X.S. Eukaryot. Cell 3 (2004) 932
8. Mellor H., and Parker P.J. Biochem. J. 332 (1998) 281
9. Evcimen N.D., and King G.L. Pharmacol. Res. 55 (2007) 498
10. Jirousek M.R., Gilling J.R., Gonzalez C.M., Heath W.F., McDonald III J.H., Neel D.A., Rito C.J., Singh U., Stramm L.E., Melikian-Badalian A., Baevsky M., Ballas L.M., Hall S.E., Winneroski L.L., and Faul M.M. J. Med. Chem. 39 (1996) 2664
11. Beckman J.A., Goldfine A.B., Gordon M.B., Garreett L.A., and Creager M.A. Circ. Res. 90 (2002) 107
12. Tuttle K.R., Bakris G.L., Toto R.D., McGill J.B., Hu K., and Anderson P.W. Diabetes Care 28 (2005) 2686
13. Aiello L.P., Clermont A., Arora V., Davis M.D., Sheetz M.J., and Bursell S.-E. Invest. Ophthalmol. Vis. Sci. 47 (2006) 86
14. Speakman, J. -B.; Karl, R.; Lorenz, G.; Ammermann, E.; Wuerzer, B.; Meyer, N.; Ditrich, K. U.S. Patent 4,983,587, 1991.
15. 3) peaks because of intramolecular hydrogen bonds. 1-OH(δ10.55 ppm) with the 9-carbonyl group; 3-OH(δ12.98 ppm) with 4-amide; 7-OH(δ18.83 ppm) with the 8-acetyl group. We determined the structure of compound 3 because the peak around 13 ppm disappeared.
16. Kutney J.P., Sanchez I.H., and Yee T. Can. J. Chem. 54 (1976) 3713
17. Yamamoto S., Hashiguchi S., Miki S., Igata Y., Watanabe T., and Shiraishi M. Chem. Pharm. Bull. 44 (1996) 734